Editor(s): Editor-in-Chief: David Y Graham and Assistant Editor: Francis Megraud
Impact Factor: 3.429
Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma.
New helicobacter species are now regularly being discovered. By broadening the scope of the Journal to the entire field of helicobacter research, we will increase communication among the various fields such as gastroenterology, microbiology, vaccine development and laboratory animal science.
As new discoveries in molecular biology and clinical trials of new treatment open up a wide range of possibilities for patient care and cure, Helicobacter will be there to report the results.